ARV-771 Acts as an Inducer of Cell Cycle Arrest and Apoptosis to Suppress Hepatocellular Carcinoma Progression
Hepatocellular carcinoma (HCC) is the most commonly diagnosed liver cancer with limited treatment options and extremely poor prognosis worldwide. Recently, the proteolysis targeting chimeras (PROTACs), which aim to induce proteasome-mediated degradation of interesting proteins via recruiting E3 liga...
Main Authors: | Yuanfei Deng, Cuifu Yu, Lushi Chen, Xin Zhang, Qiucheng Lei, Qing Liu, Gengxi Cai, Fang Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.858901/full |
Similar Items
-
Consumer Law and Environmental Protection: Consumer Sales Directive 2019/771 Example
by: Agnė Selvestravičiūtė
Published: (2023-07-01) -
Galactose-decorated liver tumor-specific nanoliposomes incorporating selective BRD4-targeted PROTAC for hepatocellular carcinoma therapy
by: Aishwarya Saraswat, et al.
Published: (2022-01-01) -
Choosing the Right Pest Control Operator for Honey Bee Removal: A Consumer Guide
by: Michael K. O'Malley, et al.
Published: (2009-01-01) -
Evaluation of the Nigerian national antiretroviral (ARV) treatment training programme
by: E Oni Idigbe, et al.
Published: (2006-11-01) -
MONETIZAÇÃO DE DADOS PESSOAIS NA INTERNET: COMPETÊNCIA REGULATÓRIA A PARTIR DO DECRETO Nº 8.771/2016
by: Victor Miguel Barros de Carvalho, et al.
Published: (2018-08-01)